Key result
A survey of British consultant cardiologists revealed that 72% (60 respondents) prescribe long-term beta blockers prophylactically after myocardial infarction even without other indications.
Why the study?
What are the current practices of British consultant cardiologists regarding prophylactic long-term beta-blocker prescription after myocardial infarction?
Cross-Sectional (n=83)
What are the current practices of British consultant cardiologists regarding prophylactic long-term beta-blocker prescription after myocardial infarction?
A survey of British cardiologists indicates that the favorable evidence from clinical trials regarding prophylactic beta-blocker use post-MI has been widely adopted into clinical practice.
Shows common prophylactic beta-blocker use after MI among UK cardiologists; leaves open alignment with contemporary outcomes data.
A survey of British consultant cardiologists was carried out to elicit their current practices when prescribing long term beta blockers after myocardial infarction. Sixty (72%) of the respondents reported that they used beta blockers prophylactically even in the absence of any other indications; the details of their stated policies, however, varied considerably. The favourable evidence of clinical trials in this indication appears to have been assimilated into hospital practice.
No takes yet. Share an insight, caveat, or question.
Baber et al. (1984) conducted a cross-sectional in myocardial infarction (n=83). beta blockers was evaluated on prophylactic use of beta blockers in the absence of other indications. A survey of British consultant cardiologists revealed that 72% (60 respondents) prescribe long-term beta blockers prophylactically after myocardial infarction even without other indications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: